Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 16714-524

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 16714-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mg-100btl (120mg 100btl)

This is a description of medication called Diltiazem Hydrochloride Extended-Release Capsules, USP with 120mg of once-a-day dosage within 100 capsules manufactured by Northstar Rx LLC. The capsules contain 120g of the drug and must be stored at 20°C to 25°C with excursions permitted up to 15°C to 30°C. The package insert should be consulted for the usual dosage. The medication should be kept in a tight, light-resistant USP container and tightly closed. The manufacturer of the drug is Apotex Inc. located in Toronto, Ontario, Canada. The transcription of some text is not perfect, but the available text provides relevant information.*

FDA Label Image

180mg-100btl (180mg 100btl)

The text describes a medication called Diltiazem Hydrochloride Extended-Release Capsules, USP, with a once-a-day dosage of 180 mg. The medication consists of 100 capsules, and each capsule contains 180 g of Diltiazem Hydrochloride. The medication should be stored between 20°C to 25°C and can be kept in excursions permitted to 15°C and 30°C [see USP controlled room temperature]. The medication should be dispensed in a tight, light-resistant container and kept tightly closed. The usual dosage should be taken as per the package insert. The medication is manufactured by Northstar Rx LLC and Apotex Inc in Memphis and Toronto, respectively.*

FDA Label Image

240mg-100btl (240mg 100btl)

This is a description of Diltiazem Hydrochloride Extended-Release Capsules sold by Northstar HealthCare Holdings. Each capsule contains 240mg of the active ingredient, which is used for treating hypertension, angina, and certain heart rhythm disorders. The capsules are sold in a package of 100 and should be stored within a specific temperature range. This medicine should be dispensed in a tightly closed, light-resistant container. The dosage information is provided within the package. The manufacturer is Apotex Inc, located in Toronto, Canada.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.